Effects of domain-switching and site-directed mutagenesis on the properties and functions of the VP7 proteins of two orbiviruses

Virology

Volumn 237, Issue 2, 1997, Pages 217-227

  Monastyrskaya, Katherine ^a,b   Staeuber, Norbert ^a,b   Sutton, Geoff ^a,b   Roy, Polly ^a,b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN;

AFRICAN HORSE SICKNESS VIRUS; ANIMAL CELL; ARTICLE; BLUETONGUE ORBIVIRUS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; ORBIVIRUS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PURIFICATION; SITE DIRECTED MUTAGENESIS;

AFRICAN HORSE SICKNESS VIRUS 4; ANIMALIA; BLUETONGUE VIRUS; EQUUS CABALLUS; ORBIVIRUS;

EID: 0030716264     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8776     Document Type: Article

References (37)

1. Basak A. K., Stuart D. I., Roy P. Preliminary crystallographic study of bluetongue virus capsid protein, VP7. J. Mol. Biol. 228:1992;687-689.
2. Basak A. K., Gouet P., Grimes J., Roy P., Stuart D. Crystal structure of the top domain of African horsesickness virus VP7: Comparisons with bluetongue virus VP7. J. Virol. 70:1996;3797-3806.
3. Brown M., Faulkner P. A plaque assay for nuclear polyhedrosis viruses using a solid overlay. J. Gen. Virol. 36:1977;361-364.
4. Burroughs J. N., O'Hara R. S., Smale C. J., Hamblin C., Walton A., Armstrong R., Mertens P. P. C. Purification and properties of virus particles, infectious subviral particles, cores and VP7 crystals of African horsesickness virus serotype 9. J. Gen. Virol. 75:1994;1849-1857.
5. Burroughs J. N., Grimes J. M., Mertens P. P. C., Stuart D. Crystallisation and preliminary X-ray analysis of the core particle of bluetongue virus. Virology. 210:1995;217-220.
6. Chuma T., Le Blois H., Sanchez-Vizcaino J. M., Diaz-Laviada M., Roy P. Expression of the major core antigen VP7 of African horsesickness virus by a recombinant baculovirus and its use as a group-specific diagnostic reagent. J. Gen. Virol. 73:1992;925-931.
7. Clapp L. L., Patton J. T. Rotavirus morphogenesis: domains in the major inner capsid protein essential for binding to single-shelled particles and for trimerisation. Virology. 180:1991;697-708.
8. Felgner P. L., Gadek T. R., Holm M., Roman R., Chan H. W., Wenz H., Northrop J. P., Ringold G. M., Danielsen M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA. 84:1987;7413-7417.
9. Fox G., Parry N. R., Barnett P. V., McGinn B., Rowlands D. J., Brown F. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (Arginine-Glycine-Aspartic acid). J. Gen. Virol. 70:1989;625-637.
10. French T. J., Roy P. Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV. J. Virol. 64:1990;1530-1536.
11. Gould E. A., Buckley A., Cammack N. Use of the biotin-streptavidin interaction to improve flavivirus detection by immunofluorescence and ELISA tests. J. Virol. Methods. 11:1985;41-48.
12. Grimes J., Basak A. K., Roy P., Stuart D. The crystal structure of bluetongue virus VP7. Nature. 373:1995;167-170.
13. Hewat E. A., Booth T. F., Roy P. Structure of bluetongue virus particles by cryo-electron microscopy. J. Struct. Biol. 109:1992a;61-69.
14. Hewat E. A., Booth T. F., Loudon P. T., Roy P. 3D reconstruction of bluetongue virus core-like particles by cryo-electron microscopy. Virology. 189:1992b;10-20.
15. Hewat E. A., Booth T. F., Roy P. Structure of correctly self-assembled bluetongue virus-like particles. J. Struct. Biol. 112:1994;183-191.
16. Iwata H., Chuma T., Roy P. Characterization of the genes encoding two of the major capsid proteins of epizootic haemorrhagic disease virus indicates a close genetic relationship to bluetongue virus. J. Gen. Virol. 73:1992a;915-924.
17. Iwata H., Yamagawa M., Roy P. Evolutionary relationships among the gnat-transmitted orbiviruses that cause African horsesickness, bluetongue and epizootic haemorrhagic disease as evidenced by their capsid protein sequences. Virology. 191:1992b;251-261.
18. Izard J., Parker M. W., Chartier M., Duche D., Baty D. A single amino acid substitution can restore solubility of aggregated colicin A mutants inEscherichia coli. Protein Eng. 7:1994;1495-1500.
19. Jenkins T. M., Enlgeman A., Ghirlando R., Craigie R. A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxy-terminal domains in multimerisation. J. Biol. Chem. 271:1996;7712-7718.
20. Kimura-Kuroda J., Yasui K. Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus using monoclonal antibodies. J. Virol. 45:1983;124-132.
21. King L. A., Possee R. D. The Baculovirus Expression System: A Laboratory Guide. 1992;Chapman & Hall, London.
22. Kitts P. A., Possee R. D. A method for producing recombinant baculovirus expression vectors at high efficiency. BioTechniques. 14:1993;810-817.
23. Kunkel T. A., Roberts J. D., Zakuor R. A. Rapid and efficient method of site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:1987;367-382.
24. LeBlois H., Fayard B., Urakawa T., Roy P. Synthesis and characterization of chimeric particles between epizootic haemorrhagic disease virus and bluetongue virus: Functional domains are conserved on the VP3 proteins. J. Virol. 65:1991;4821-4831.
25. LeBlois H., Roy P. A single point mutation in the VP7 major core protein of Bluetongue virus prevents the formation of core-like particles. J. Virol. 67:1993;353-359.
26. Livingstone C., Jones I. M. Baculovirus expression vector with single-strand capability. Nucleic Acids Res. 17:1989;2366.
27. Logan D., Abu-Ghazaleh R., Blakemore W., Curry S., Jackson T., King A., Lea S., Lewis R., Newman J., Parry N., Rowlands D., Stuart D., Fry E. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature. 362:1993;566-568.
28. Mason P. W., Reider E., Baxt B. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc. Natl. Acad. Sci. USA. 91:1994;1932-1936.
29. Matsuura Y., Possee R. D., Overton H. A., Bishop D. H. Baculovirus expression vectors: The requirements for high level expression of proteins, including glycoproteins. J. Gen. Virol. 68:1987;1233-1250.
30. Murphy F. A., Borden E. C., Slope R. E., Harrison A. Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus - A new taxonomic group. Electron microscopic studies. J. Gen. Virol. 13:1971;273-288.
31. Oldfield S., Adachi A., Urakawa T., Hirasawa T., Roy P. Purification and characterization of the major group-specific core antigen VP7 of bluetongue virus synthesized by a recombinant baculovirus. J. Gen. Virol. 71:1990;2649-2656.
32. Prasad B. V. V., Yamaguchi S., Roy P. Three-dimensional structure of single-shelled BTV. J. Virol. 66:1992;2135-2142.
33. Roy P., Hirasawa T., Fernandez M., Blinov V. M., Sanchez-Vixcaino Rodrique J. M. The complete sequence of the group-specific antigen, VP7, of African horsesickness virus serotype 4 reveals a close relationship to bluetongue virus. J. Gen. Virol. 72:1991;1237-1241.
34. Roy P. Orbivirus structure and assembly. Virology. 216:1996a;1-11.
35. Roy P. Orbiviruses and their replication. Fields Virology. 1996b;Lippincott-Raven, Philadelphia. p. 1709-1734.
36. Sanger J. A., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
37. Zhao G. P., Sommerville R. L. Genetic and biochemical characterization of the trpB8 mutation of Escherichia coli tryptophan synthase: An amino acid switch at the sharp turn of the trypsin-sensitive "hinge" region diminishes binding and alters solubility. J. Biol. Chem. 267:1992;526-541.